The findings will serve as a reference for clinical professionals to promote exercise among the general population for improving HRV.
Background: Heart rate variability (HRV) measurement is widely used to assess the function of cardiac autonomic modulation. Aerobic exercise (AE) has been proven to improve HRV. However, because HRV is highly associated with visceral fat, inflammatory status, and insulin resistance, whether baseline body inflammation status can explain the heterogeneous response to AE remains unknown. Purposes: We will compare the effects of AE training in improving HRV, inflammatory markers, and insulin resistance between community residents with normal weight and overweight/obesity. Methods: A quasi-experimental study with purposive sampling will be used to recruit community residents aged 40-64 years with inactive habits in southern Taiwan. The minimum targeted sample size is 43 participants. The participants will be grouped into normal weight and overweight/obese groups. All participants will receive AE training with at least moderate intensity three times per week. HRV parameters, blood samples, and visceral fat will be evaluated. The blood samples will be evaluated for C-reactive protein and markers of insulin resistance (fasting glucose, insulin). All participants will be evaluated at baseline (T0) and after a 16-week intervention (T1). In addition to these time points, HRV will be measured during every exercise session for participants in exercise groups. Generalized estimating equations will be used to determine whether baseline BMI is the key factor influencing the effects of AE. Relevance to clinical practice: The findings will serve as a reference for clinical professionals to promote exercise among the general population for improving HRV.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
51
The participants will receive AE three times per week.
Yu-Hsuan Chang
Tainan, Taiwan
Heart rate variability
will use heart rate variability analyzer
Time frame: two times and each session of exercise (change from baseline to the end of 16-week)
insulin resistance
μIU/mL
Time frame: two times (change from baseline to the end of 16-week)
Visceral fat
will use body composition analyzer
Time frame: two times (change from baseline to the end of 16-week)
fasting glucose
mg/dL
Time frame: two times (change from baseline to the end of 16-week)
C-reactive protein
mg/L
Time frame: two times (change from baseline to the end of 16-week)
Waist-to-hip ratio
Waist-to-hip ratio
Time frame: two times (change from baseline to the end of 16-week)
Waist-to-height ratio
Waist-to-height ratio
Time frame: two times (change from baseline to the end of 16-week)
body weight
weight in Kilogram
Time frame: two times (change from baseline to the end of 16-week)
BMI
weight and height will be combined to report BMI in kg/m\^2
Time frame: two times (change from baseline to the end of 16-week)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.